A novel asexual blood-stage malaria vaccine candidate: PfRipr5 formulated with human-use adjuvants induces potent growth inhibitory antibodies

PfRipr is a highly conserved asexual-blood stage malaria vaccine candidate against Plasmodium falciparum. PfRipr5, a protein fragment of PfRipr inducing the most potent inhibitory antibodies, is a promising candidate for the development of next-generation malaria vaccines, requiring validation of it...

Descripción completa

Detalles Bibliográficos
Autores principales: Takashima, Eizo, Nagaoka, Hikaru, Correia, Ricardo, Alves, Paula M., Roldão, António, Christensen, Dennis, Guderian, Jeffrey A., Fukushima, Akihisa, Viebig, Nicola K., Depraetere, Hilde, Tsuboi, Takafumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647036/
https://www.ncbi.nlm.nih.gov/pubmed/36389677
http://dx.doi.org/10.3389/fimmu.2022.1002430

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647036/
https://www.ncbi.nlm.nih.gov/pubmed/36389677
http://dx.doi.org/10.3389/fimmu.2022.1002430

Ejemplares similares